# Antihyperglycemic and Antioxidative Stress Effects of Erythrophleum africanum (Fabaceae) Trunk Bark Powder Fractions on High‐Calorie Diet‐Induced Type 2 Diabetes in Rats

**Authors:** Mathieu Sini, Faustin Dongmo, Clemence Mvongo, Michel Archange Fokam Tagne, Pierre Jidibe, Angèle Foyet Fondjo, Paul Aimé Noubissi, René Kamgang

PMC · DOI: 10.1002/fsn3.70290 · Food Science & Nutrition · 2025-05-14

## TL;DR

This study shows that a fine powder from Erythrophleum africanum can help prevent type 2 diabetes in rats by lowering blood sugar and improving cholesterol levels.

## Contribution

The study demonstrates the antihyperglycemic and antioxidative effects of fine Erythrophleum africanum powder in a rat model of type 2 diabetes.

## Key findings

- The fine powder (≤ 50 μm) of E. africanum significantly reduced blood glucose levels in diabetic rats.
- The powder improved lipid profiles by lowering triglycerides and LDL cholesterol while increasing HDL cholesterol.
- E. africanum powder showed less toxicity to the liver and kidneys compared to other treatments.

## Abstract

Diabetes mellitus is a persistent and chronic metabolic disease characterized by high blood glucose levels. The aim of this work was to evaluate the antihyperglycemic and antioxidative stress effects of Erythrophyllum africanum trunk bark powder fractions in diabetes‐induced rats. 30 male rats subdivided into 6 groups of five rats each received daily a sweetened hypercaloric diet supplemented with sucrose (4 g/kg bw), except for the normal control, which received a normal diet. Normal and diabetic controls subsequently received distilled water (10 mL/kg bw per os), the positive control received metformin (20 mg/kg bw per os) and the test rats received powder fractions (≤ 50 μm ≤ 50–120 μm) or unsieved powder of 
E. africanum
 (300 mg/kg bw per os) for 7 weeks. Dexamethasone (0.2 mg/kg) was administered intraperitoneally once a week from the third week, except for the normal control, which received saline. Fasting blood glucose, lipid profile, and biochemical parameters of oxidative stress were assessed during and at the end of treatment. Blood glucose levels of the animals at the 7th week were 0.92 ± 0.03, 1.52 ± 0.08, 0.78 ± 0.04, 0.77 ± 0.03, 1.13 ± 0.03, and 0.40 ± 0.01 g/L in the normal control, diabetic control, metformin‐treated animals, ≤ 50 μm fraction, 50–120 μm fraction, and unsieved powder, respectively. Powder fraction ≤ 50 μm significantly improved (p < 0.01) the lipid profile (decrease in triglyceride and LDL cholesterol levels, an increase in HDL cholesterol levels) by reducing the atherogenic index. 
E. africanum
 has antihyperglycemic and antioxidative stress effects and would be less toxic to the liver and kidneys. The fine powder (≤ 50 μm) of 
E. africanum
 could be used as a food additive to prevent the occurrence of diabetes in vulnerable patients.

The powder fraction of Erythrophleum africanum with a size less than 50 μm prevents the occurrence of type 2 diabetes induced by the combination of a high‐calorie diet and the intake of dexamethasone. 
E. africanum
 has antihyperglycemic and antioxidative stress effects and improves the lipid profile by reducing the atherogenic index. This plant would be less toxic to the liver and kidneys.

## Linked entities

- **Chemicals:** dexamethasone (PubChem CID 5743), sucrose (PubChem CID 5988), metformin (PubChem CID 4091)
- **Diseases:** type 2 diabetes (MONDO:0005148)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Lpl (lipoprotein lipase) [NCBI Gene 24539], Gpt (glutamic--pyruvic transaminase) [NCBI Gene 81670] {aka ALAT, Gpt1}, G6PC1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 2538] {aka G6PC, G6PT, G6Pase, GSD1, GSD1a}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Got2 (glutamic-oxaloacetic transaminase 2) [NCBI Gene 25721] {aka ASPATA, mAAT}, PCK1 (phosphoenolpyruvate carboxykinase 1) [NCBI Gene 5105] {aka PCKDC, PEPCK-C, PEPCK1, PEPCKC}, Hmgcr (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 25675] {aka 3H3M}, Got1 (glutamic-oxaloacetic transaminase 1) [NCBI Gene 24401] {aka AAT1, ASAT, Aspat, Gaspat, cAspAT, cCAT}, Slc2a4 (solute carrier family 2 member 4) [NCBI Gene 25139] {aka Glut4}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Podxl (podocalyxin-like) [NCBI Gene 192181] {aka PC, PCLP-1, podocalyxin}, Slc2a2 (solute carrier family 2 member 2) [NCBI Gene 25351] {aka GTT2, Glut2}
- **Diseases:** cardiovascular damage (MESH:D002318), hyperlipidemia (MESH:D006949), dyslipidemia (MESH:D050171), hyperglycemia (MESH:D006943), dysentery (MESH:D004403), anorexia (MESH:D000855), insulin resistance (MESH:D007333), ADA (MESH:C531816), T2D (MESH:D003924), type 1 (T1D (MESH:D003922), goiter (MESH:D006042), diarrhea (MESH:D003967), heart failure (MESH:D006333), deaths (MESH:D003643), inflammations (MESH:D007249), metabolic disease (MESH:D008659), vitamin B12 (MESH:D014806), hyperglycemic (MESH:D006944), hypoglycemia (MESH:D007003), vomiting (MESH:D014839), atherogenic (MESH:D050197), loss of body weight (MESH:D001835), leprosy (MESH:D007918), Diabetes (MESH:D003920), sexually transmitted diseases (MESH:D012749), malabsorption (MESH:D008286), necrosis (MESH:D009336)
- **Chemicals:** potassium dichromate (MESH:D011192), MDA (MESH:D008315), acetic acid (MESH:D019342), TG (MESH:D014280), water (MESH:D014867), Saponins (MESH:D012503), polyethylene (MESH:D020959), fatty acids (MESH:D005227), Lipid (MESH:D008055), Dexamethasone (MESH:D003907), thiazolidinediones (MESH:D045162), adrenaline (MESH:D004837), Blood glucose (MESH:D001786), thiobarbituric acid (MESH:C029684), Erythrophyllum africanum (-), glycerol (MESH:D005990), GSH (MESH:D005978), MC (MESH:C061001), HCl (MESH:D006851), TCA (MESH:D014238), flavonoids (MESH:D005419), L-arginine (MESH:D001120), polysaccharides (MESH:D011134), sulphonamides (MESH:D013449), reactive oxygen species (MESH:D017382), phosphate (MESH:D010710), Creatinine (MESH:D003404), sucrose (MESH:D013395), free radicals (MESH:D005609), biguanides (MESH:D001645), Nitrite (MESH:D009573), polyphenols (MESH:D059808), tannins (MESH:D013634), carbonate (MESH:D002254), NO (MESH:D009569), Griess reagent (MESH:C095000), diazepam (MESH:D003975), cardiac glycosides (MESH:D002301), D-glucose (MESH:D005947), cholesterol (MESH:D002784), Metformin (MESH:D008687), sugar (MESH:D000073893), H2O2 (MESH:D006861)
- **Species:** Homo sapiens (human, species) [taxon 9606], Erythrophleum africanum (species) [taxon 869757], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12076005/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12076005/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12076005/full.md

---
Source: https://tomesphere.com/paper/PMC12076005